Healthcare Committee

  • The Aim of the Healthcare Committee of AmCham Estonia is to provide Estonian policymakers, institutions and other relevant stakeholders with the perspective of US companies that operate in Estonia. Health is an important driver for wealth and economic growth. The Committee therefore would support the EU health agenda towards affordable, sustainable and innovative health systems. Composed of the various healthcare industries (pharmaceuticals, eHealth, medical devices, consumer, and transport industries), it would to be a reliable policy partner to the Estonian institutions and to help ensure that new healthcare-related legislations and policies add value to, and benefit, the entire healthcare ecosystem.

To view the latest position paper by the AmCham Healthcare Committee please CLICK HERE

Here are some of the most relevant issues the committee was addressing in 2019:

Based on many recent and not so recent studies Estonian healthcare financing system (lack of funds in EHIF) is not sustainable in the changed environment (aging population, increased expectation, innovation in HC etc). The committee is trying to identify what are the short and long term plans to make the Estonian HC future-proof.

In approximately half of the European countries, Value Added Tax of prescription medicines is lower than in Estonia (for example 6% in the Netherlands, 5% in Lithuania, 4% in Spain, 2,1% in France compared to 9% in Estonia). High proportional VAT increases especially the price of innovative new pharmaceuticals, creates an additional burden to the Health Insurance Fund and restricts access to new treatments for Estonian patients. The committee is trying to offer a change in the taxation system in order to address the issue.

Background: Today we are measuring healthcare by different input KPIs (number of nights in the hospital, cost of treatment procedures or process quality KPIs (waiting list for medical treatment), but instead we should measure and incentivize patient-centric quality of life KPIs like social functioning, self-care etc. Those KPIs have been developed and validated internationally (https://www.ichom.org/standard-sets/), but none of the countries haven’t yet implemented those nationwide. Estonia could be the leader here, as we do have digital capabilities and we are small. The committee is trying to promote the support of establishing or piloting patient-centric value-based healthcare.

Committee Members:

    1. Elo Tamm, COBALT Law Office (Committee Chair)
    2. Hanno Püttsepp, Amgen (Committee Co-Chair)
    3. Liudvika Starkiene, Amgen
    4. Daria Sivovol, AmCham Estonia
    5. Madis Aaren, AbbVie
    6. Sonata Matuleviciene, AstraZeneca
    7. Pille Pihlakas, AstraZeneca
    8. Triin Parik, AstraZeneca
    9. Daniela Pavlic, AstraZeneca
    10. Martin Minin, Semetron (Medical Devices) 
    11. Siiri Võlu-Tiganik, HansaMedical OÜ (Medical Devices)
    12. Kärt Tali, Bayer
    13. Edgars Skvariks, Bayer
    14. Mikko Fernström, Biogen
    15. Andrei Nahkala, Biogen
    16. Jolanta Dickute, Biogen
    17. Piibe Veiram, Biogen
    18. Rima Valentukeviciene, IBM
    19. Michal Pilkiewicz, IQVIA 
    20. Kaspars Grosu, IQVIA
    21. Andrius Girzadas, IQVIA
    22. Jane Kesküla, Johnson & Johnson
    23. Laura Saar, Johnson & Johnson
    24. Kairit Sildre, Johnson & Johnson 
    25. Giedre Kuldmäe, Johnson & Johnson (MedTech)
    26. Tarmo Toiger, KPMG
    27. Vladimir Ossipov, Marsh 
    28. Marit Järv, Marsh
    29. Margus Läänesaar, Medtronic 
    30. Andrius Grigosaitis, Medtronic
    31. Ruthy Kaidar, Microsoft
    32. Ema Popova, Microsoft
    33. Svetlana Nikkinen, Microsoft
    34. Imants Sinka, MSD
    35. Kadri Päll, MSD 
    36. Andres Müürsepp, MSD
    37. Pille Loit, M-Ring
    38. Marki-Tihhonova-Kreek, Nortal
    39. Karin Varrak, Novartis
    40. Rudolf Põld, Novartis
    41. Alice Kivistik, Pfizer
    42. Anneli Truhanov, Pfizer
    43. Mart Vain, Roche
    44. Kadri Mägi-Lehtsi, Roche
    45. Evita Feldberga, Roche
    46. Lise-Lotte Lääne, Sorainen
    47. Merilin Varsamaa, Tallinn Science Park Tehnopol
    48. Taimi Veedla, U.S. Embassy Tallinn
    49. Ingeri Luik-Tamme, TGS Baltics

    Some of our past activities and events:

    2024 Highlights:

    2023 Highlights:

     
    Previous activities;

    AmCham HC Committee Meeting with Rain Laane, Chairman of the Estonian Health Insurance Fund (February 16, 2022)

    AmCham Healthcare Committee meeting 2021/1

    AmCham Healthcare Committee Round Table Meeting

    Amcham Healthcare Committee Meets with the Social Ministry Representative

    AmCham Estonia and AmCham Healthcare Committee Hold the 2nd Annual Healthcare Conference, This Time Dedicated to Data and Data-Driven Healthcare

    Healthcare Committee Meets with the Social Ministry Representatives 

    Healthcare Committee Meets with the New Chairman of the Board of HIF, Rain Laane

    AmCham Healthcare Committee Holds its First Morning Breakfast Round Table Discussion with Minister Ossinovski and Tanel Ross, Haigekassa

    AmCham Healthcare Committee Meets for its 3rd Meeting

    AmCham Healthcare Committee Position Paper

     AmCham Launches a Healthcare Committee

    Please find the newest AmCham Member offers below, more discount partner programs can be found by clicking the link below. 

    Please find the newest AmCham Member offers below, more discount partner programs can be found by clicking the link below. 

    Recent News

    view all
    Search
    © 2024 All rights reserved AmCham